Surmodics (SRDX)
(Delayed Data from NSDQ)
$32.37 USD
+0.15 (0.47%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $32.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Surmodics, Inc. has a market cap of $460.67M, which represents its share price of $32.22 multiplied by its outstanding shares number of 14.30M. As a small-cap company, SRDX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SRDX 32.37 +0.15(0.47%)
Will SRDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SRDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRDX
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
SRDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates
Other News for SRDX
Technical picture remains unchanged for SRDX after it rises 0.99% on September 18
Technical picture remains unchanged for SRDX after it falls 0.05% on September 17
SRDX's price falls by 1.39% on September 16, though its technical setup remains stable.
The technical outlook for SRDX is unchanged after it rises 1.28% on September 15
Technical picture remains unchanged for SRDX after it falls 0.96% on September 12